Imunon

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Imunon and other ETFs, options, and stocks.

About IMNN

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. 

CEO
Stacy R. Lindborg
CEOStacy R. Lindborg
Employees
20
Employees20
Headquarters
Lawrenceville, New Jersey
HeadquartersLawrenceville, New Jersey
Founded
1982
Founded1982
Employees
20
Employees20

IMNN Key Statistics

Market cap
6.35M
Market cap6.35M
Price-Earnings ratio
-0.29
Price-Earnings ratio-0.29
Dividend yield
Dividend yield
Average volume
412.37K
Average volume412.37K
High today
$1.64
High today$1.64
Low today
$1.50
Low today$1.50
Open price
$1.63
Open price$1.63
Volume
91.73K
Volume91.73K
52 Week high
$9.42
52 Week high$9.42
52 Week low
$1.50
52 Week low$1.50

Stock Snapshot

As of today, Imunon(IMNN) shares are valued at $1.60. The company's market cap stands at 6.35M, with a P/E ratio of -0.29.

On 2026-07-25, Imunon(IMNN) stock traded between a low of $1.50 and a high of $1.64. Shares are currently priced at $1.60, which is +6.7% above the low and -2.4% below the high.

Imunon(IMNN) shares are trading with a volume of 91.73K, against a daily average of 412.37K.

During the past year, Imunon(IMNN) stock moved between $1.50 at its lowest and $9.42 at its peak.

During the past year, Imunon(IMNN) stock moved between $1.50 at its lowest and $9.42 at its peak.

IMNN News

Investing.com 2d
IMUNON presents ovarian cancer therapy data at AACR conference - Investing.com

...

IMUNON presents ovarian cancer therapy data at AACR conference - Investing.com
TipRanks 4d
Imunon announces new preliminary data from IMNN-001 trial

Imunon (IMNN) announced new preliminary data from its ongoing Phase 2 minimal residual disease, or MRD, translational clinical trial of IMNN-001, conducted in c...

People also own

Based on the portfolios of people who own IMNN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.